FDA Charts Transparency Plans | GenomeWeb

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Food and Drug Administration has issued a report detailing its plans to enhance the agency’s transparency and communications efforts to the industries it regulates, which include the recent launch of a website to provide companies with submission and regulatory information, and it is seeking public comments on some of these plans.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.